316 related articles for article (PubMed ID: 11747812)
21. RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini.
Gonzalez-Suarez E; Branstetter D; Armstrong A; Dinh H; Blumberg H; Dougall WC
Mol Cell Biol; 2007 Feb; 27(4):1442-54. PubMed ID: 17145767
[TBL] [Abstract][Full Text] [Related]
22. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
24. Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression.
Geymayer S; Doppler W
FASEB J; 2000 Jun; 14(9):1159-70. PubMed ID: 10834938
[TBL] [Abstract][Full Text] [Related]
25. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.
Brisken C; Ayyannan A; Nguyen C; Heineman A; Reinhardt F; Tan J; Dey SK; Dotto GP; Weinberg RA
Dev Cell; 2002 Dec; 3(6):877-87. PubMed ID: 12479812
[TBL] [Abstract][Full Text] [Related]
26. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
27. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
Nakashima T; Kobayashi Y; Yamasaki S; Kawakami A; Eguchi K; Sasaki H; Sakai H
Biochem Biophys Res Commun; 2000 Sep; 275(3):768-75. PubMed ID: 10973797
[TBL] [Abstract][Full Text] [Related]
28. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
[TBL] [Abstract][Full Text] [Related]
29. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
30. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.
Zhang J; Warren MA; Shoemaker SF; Ip MM
Endocrinology; 2007 Jan; 148(1):268-78. PubMed ID: 17008396
[TBL] [Abstract][Full Text] [Related]
31. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145
[TBL] [Abstract][Full Text] [Related]
32. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.
Hofbauer LC; Kluger S; Kühne CA; Dunstan CR; Burchert A; Schoppet M; Zielke A; Heufelder AE
J Cell Biochem; 2002; 86(4):642-50. PubMed ID: 12210731
[TBL] [Abstract][Full Text] [Related]
33. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
Jiang R; Xia Y; Li J; Deng L; Zhao L; Shi J; Wang X; Sun B
Int J Cancer; 2010 Mar; 126(5):1263-74. PubMed ID: 19728335
[TBL] [Abstract][Full Text] [Related]
34. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.
Chan CB; Liu X; Ensslin MA; Dillehay DL; Ormandy CJ; Sohn P; Serra R; Ye K
EMBO J; 2010 Mar; 29(5):956-68. PubMed ID: 20075866
[TBL] [Abstract][Full Text] [Related]
35. Targeted expression of GLI1 in the mammary gland disrupts pregnancy-induced maturation and causes lactation failure.
Fiaschi M; Rozell B; Bergström A; Toftgård R; Kleman MI
J Biol Chem; 2007 Dec; 282(49):36090-101. PubMed ID: 17928300
[TBL] [Abstract][Full Text] [Related]
36. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA
J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704
[TBL] [Abstract][Full Text] [Related]
37. Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
Klauzinska M; McCurdy D; Rangel MC; Vaidyanath A; Castro NP; Shen MM; Gonzales M; Bertolette D; Bianco C; Callahan R; Salomon DS; Raafat A
Am J Pathol; 2015 Nov; 185(11):2907-22. PubMed ID: 26429739
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
Swanson C; Lorentzon M; Conaway HH; Lerner UH
Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
[TBL] [Abstract][Full Text] [Related]
39. NF-kappaB in mammary gland development and breast cancer.
Cao Y; Karin M
J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):215-23. PubMed ID: 14635796
[TBL] [Abstract][Full Text] [Related]
40. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
Williamson E; Bilsborough JM; Viney JL
J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
